Karpus Investment Management’s Generation Asia I Acquisition Limited Class A Ordinary Shares GAQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-194,820
Closed -$2.18M 231
2024
Q3
$2.18M Sell
194,820
-4,200
-2% -$47.2K 0.06% 166
2024
Q2
$2.24M Sell
199,020
-7,000
-3% -$78.1K 0.06% 157
2024
Q1
$2.27M Sell
206,020
-15,955
-7% -$175K 0.07% 161
2023
Q4
$2.41M Sell
221,975
-174,925
-44% -$1.89M 0.07% 158
2023
Q3
$4.25M Sell
396,900
-4,275
-1% -$45.3K 0.14% 123
2023
Q2
$4.22M Hold
401,175
0.13% 136
2023
Q1
$4.14M Buy
401,175
+3,000
+0.8% +$30.8K 0.13% 141
2022
Q4
$4.03M Sell
398,175
-15,425
-4% -$154K 0.14% 143
2022
Q3
$4.12M Buy
413,600
+39,250
+10% +$389K 0.14% 159
2022
Q2
$3.67M Buy
+374,350
New +$3.67M 0.12% 179

Karpus Investment Management's GAQ Position: Q4 2024 in Review

Karpus Investment Management sold out of Generation Asia I Acquisition Limited Class A Ordinary Shares (GAQ) in Q4 2024, closing a stake of 194,820 shares — an estimated $2.18M sold.

Karpus Investment Management first reported a position in GAQ in Q2 2022 and held it in 10 quarters. The position peaked at $4.25M in Q3 2023. 0 funds tracked by Wall St. Rank hold GAQ as of Q4 2024.

  • Karpus Investment Management reported no remaining Generation Asia I Acquisition Limited Class A Ordinary Shares position as of Q4 2024 after selling out during the quarter.
  • Karpus Investment Management sold 194,820 Generation Asia I Acquisition Limited Class A Ordinary Shares shares in Q4 2024, an estimated $2.18M.
  • Karpus Investment Management first reported a position in Generation Asia I Acquisition Limited Class A Ordinary Shares in Q2 2022 and held it in 10 quarters.
  • Karpus Investment Management's Generation Asia I Acquisition Limited Class A Ordinary Shares position peaked at $4.25M in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Generation Asia I Acquisition Limited Class A Ordinary Shares as of Q4 2024.

Based on Karpus Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.